Journal article
Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab.
Abstract
BACKGROUND: This study aimed to examine the risk of respiratory-related hospitalization in children with neurologic and muscular disorders (NMDs) who received respiratory syncytial virus (RSV) prophylaxis in the Canadian RSV Evaluation Study of Palivizumab.
METHODS: Canadian RSV Evaluation Study of Palivizumab is a prospective registry of children who received ≥1 palivizumab injection among 32 Canadian sites. Demographic data were collected at …
Authors
Wang DY; Saleem M; Paes BA; Mitchell I; Li A; Lanctôt KL
Journal
The Pediatric Infectious Disease Journal, Vol. 38, No. 8, pp. 775–780
Publisher
Wolters Kluwer
Publication Date
August 2019
DOI
10.1097/inf.0000000000002297
ISSN
0891-3668